Latest Novo Holdings A/S Stock Portfolio
Novo Holdings A/S Performance:
2025 Q3: 11.09%YTD: 0.39%2024: -2.45%
Performance for 2025 Q3 is 11.09%, and YTD is 0.39%, and 2024 is -2.45%.
About Novo Holdings A/S and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, NOVO HOLDINGS A/S reported an equity portfolio of $1.6 Billions as of 30 Sep, 2025.
The top stock holdings of NOVO HOLDINGS A/S are VB, , . The fund has invested 22% of it's portfolio in VANGUARD INDEX FDS and 10.3% of portfolio in BROOKFIELD CORP.
The fund managers got completely rid off BLUEPRINT MEDICINES CORP (BPMC), CERIBELL INC and ABCELLERA BIOLOGICS INC (ABCL) stocks. They significantly reduced their stock positions in INSMED INC (INSM), ALIBABA GROUP HLDG LTD (BABA) and IO BIOTECH INC (IOBT). NOVO HOLDINGS A/S opened new stock positions in BRIDGEBIO ONCOLOGY THERAPEUT. The fund showed a lot of confidence in some stocks as they added substantially to ENLIVEN THERAPEUTICS INC, CRINETICS PHARMACEUTICALS IN (CRNX) and PHARVARIS N V (PHVS).
The top stock holdings of NOVO HOLDINGS A/S are VB, , . The fund has invested 22% of it's portfolio in VANGUARD INDEX FDS and 10.3% of portfolio in BROOKFIELD CORP.
The fund managers got completely rid off BLUEPRINT MEDICINES CORP (BPMC), CERIBELL INC and ABCELLERA BIOLOGICS INC (ABCL) stocks. They significantly reduced their stock positions in INSMED INC (INSM), ALIBABA GROUP HLDG LTD (BABA) and IO BIOTECH INC (IOBT). NOVO HOLDINGS A/S opened new stock positions in BRIDGEBIO ONCOLOGY THERAPEUT. The fund showed a lot of confidence in some stocks as they added substantially to ENLIVEN THERAPEUTICS INC, CRINETICS PHARMACEUTICALS IN (CRNX) and PHARVARIS N V (PHVS).
Novo Holdings A/S Annual Return Estimates Vs S&P 500
Our best estimate is that NOVO HOLDINGS A/S made a return of 11.09% in the last quarter. In trailing 12 months, it's portfolio return was -1.95%.
New Buys
| Ticker | $ Bought |
|---|---|
| bridgebio oncology therapeut | 22,712,100 |
| lanzatech global inc | 3,876,210 |
New stocks bought by Novo Holdings A/S
Additions
| Ticker | % Inc. |
|---|---|
| enliven therapeutics inc | 31.52 |
| apogee therapeutics inc | 11.26 |
| crinetics pharmaceuticals in | 4.84 |
| arrivent biopharma inc | 3.74 |
| pharvaris n v | 1.45 |
Additions to existing portfolio by Novo Holdings A/S
Reductions
| Ticker | % Reduced |
|---|---|
| insmed inc | -70.59 |
| alibaba group hldg ltd | -30.89 |
| io biotech inc | -25.1 |
| recursion pharmaceuticals in | -17.95 |
| mirum pharmaceuticals inc | -15.73 |
| galecto inc | -13.35 |
| asml holding n v | -12.06 |
| zenas biopharma inc | -11.11 |
Novo Holdings A/S reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| lanzatech global inc | -4,288,990 |
| ceribell inc | -16,857,000 |
| abcellera biologics inc | -2,238,170 |
| blueprint medicines corp | -33,962,100 |
Novo Holdings A/S got rid off the above stocks
Sector Distribution
NOVO HOLDINGS A/S has about 59% of it's holdings in Others sector.
| Sector | % |
|---|---|
| Others | 59 |
| Healthcare | 35.8 |
| Technology | 5.2 |
Market Cap. Distribution
NOVO HOLDINGS A/S has about 9.2% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| UNALLOCATED | 59 |
| SMALL-CAP | 18.5 |
| MID-CAP | 13.2 |
| MEGA-CAP | 5 |
| LARGE-CAP | 4.2 |
Stocks belong to which Index?
About 34% of the stocks held by NOVO HOLDINGS A/S either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 66 |
| RUSSELL 2000 | 29 |
| S&P 500 | 5 |
Novo Holdings A/S Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Novo Holdings A/S
NOVO HOLDINGS A/S has 27 stocks in it's portfolio. About 73.2% of the portfolio is in top 10 stocks. CRM proved to be the most loss making stock for the portfolio. MIRM was the most profitable stock for NOVO HOLDINGS A/S last quarter.
Last Reported on: 14 Nov, 2025| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ABCL | abcellera biologics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| BABA | alibaba group hldg ltd | 2.96 | 257,327 | 45,992,100 | reduced | -30.89 | ||
| BMRN | biomarin pharmaceutical inc | 2.30 | 660,000 | 35,745,600 | unchanged | 0.00 | ||
| BPMC | blueprint medicines corp | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CLDX | celldex therapeutics inc new | 2.00 | 1,200,000 | 31,044,000 | unchanged | 0.00 | ||
| CRM | salesforce inc | 5.04 | 330,187 | 78,254,300 | unchanged | 0.00 | ||
| CRNX | crinetics pharmaceuticals in | 4.36 | 1,625,000 | 67,681,200 | added | 4.84 | ||
| EWTX | edgewise therapeutics inc | 5.59 | 5,350,000 | 86,777,000 | unchanged | 0.00 | ||
| FDMT | 4d molecular therapeutics in | 1.12 | 2,000,000 | 17,380,000 | unchanged | 0.00 | ||
| GLTO | galecto inc | 0.02 | 86,579 | 322,074 | reduced | -13.35 | ||
| INSM | insmed inc | 1.86 | 200,000 | 28,802,000 | reduced | -70.59 | ||
| IOBT | io biotech inc | 0.06 | 2,512,450 | 912,272 | reduced | -25.1 | ||
| MIRM | mirum pharmaceuticals inc | 5.97 | 1,264,030 | 92,665,900 | reduced | -15.73 | ||
| MQ | marqeta inc | 0.15 | 441,558 | 2,331,430 | unchanged | 0.00 | ||
| MRUS | merus n v | 4.55 | 750,000 | 70,612,500 | unchanged | 0.00 | ||
| PCVX | vaxcyte inc | 2.13 | 916,160 | 33,000,100 | unchanged | 0.00 | ||
| PHVS | pharvaris n v | 2.81 | 1,750,000 | 43,662,500 | added | 1.45 | ||
| RXRX | recursion pharmaceuticals in | 2.49 | 7,929,840 | 38,697,600 | reduced | -17.95 | ||
| VB | vanguard index fds | 21.97 | 1,038,550 | 340,821,000 | unchanged | 0.00 | ||
| VRDN | viridian therapeutics inc | 3.31 | 2,380,000 | 51,360,400 | unchanged | 0.00 | ||